Amanote Research
Register
Sign In
P1.01-85 the Prevalence of Different EGFR Exon20 Mutations in 12,833 Chinese Lung Cancer Patients
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.641
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
Y.W. Shao
X. Tong
X. Wang
F. Wang
X. Wu
Publisher
Elsevier BV
Related search
P1.01-111 EGFR Exon20 Insertion Patients Treated With First-Line Chemotherapy in Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-56 Concurrent Mutations in Chinese Lung Cancer Patients Carrying HER2 Genomic Aberrations
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.13-46 Comprehensive Investigation of ERBB2 Transmembrane Domain Mutations (V659/G660) in 12,833 Chinese Lung Cancer Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Prevalence of EGFR Mutations and Clinico-Pathological Characteristics of Chilean Lung Cancer Patients
Asian Pacific Journal of Cancer Prevention
P1.01-105 Lung Cancer Patients With Concurrent EGFR and MET Mutations: A Retrospective Analysis of 29 Cases
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-43 Next-Generation Sequencing in the Exploration of Genetic Heterogeneity for Lung Adenocarcinoma Patients With EGFR Activating Mutations
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
EGFR Mutations Status for Non-Small-Cell Lung Cancer Patients
Sveikatos mokslai
P2.03-12 EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Brief Report: EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary